Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
210,587,372
-
Total 13F shares
-
104,536,942
-
Share change
-
-15,944,574
-
Total reported value
-
$1,063,154,138
-
Put/Call ratio
-
70%
-
Price per share
-
$10.17
-
Number of holders
-
183
-
Value change
-
-$141,911,795
-
Number of buys
-
96
-
Number of sells
-
101
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q1 2021
As of 31 Mar 2021,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
183 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
104,536,942 shares.
The largest 10 holders included
BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Sarissa Capital Management LP, STATE STREET CORP, HealthCor Management, L.P., Artisan Partners Limited Partnership, GEODE CAPITAL MANAGEMENT, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and Nuveen Asset Management, LLC.
This page lists
183
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.